SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series.
Sandeep K GillJuan Carlos Hernaiz-LeonardoThaddeus J EdensAthenea PascualChris TangJudy FanAndrew ThambooWarren MullingsSaad AlsalehBader Mohammed AlimAmin R JaverAmee R MangesPublished in: International forum of allergy & rhinology (2024)
SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days. The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis. These promising SNMT results warrant further study of safety and efficacy.